SNN

$33.37

Pre-MarketAs of Mar 17, 8:00 PM UTC

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom, the United States, and internationally.

Recent News

Zacks
Mar 11, 2026

SNN Launches ALLEVYN COMPLETE CARE Dressing for Wound Management

Smith + Nephew launches ALLEVYN COMPLETE CARE foam dressing for wound management, expanding its Advanced Wound Management portfolio.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MT Newswires
Mar 5, 2026

European Equities Traded in the US as American Depositary Receipts Slide in Thursday Trading

European equities traded in the US as American depositary receipts were sliding late Thursday mornin

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
MT Newswires
Mar 4, 2026

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

European equities traded in the US as American depositary receipts were tracking higher late Wednesd

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
GuruFocus.com
Mar 4, 2026

Smith & Nephew PLC (SNN) Full Year 2025 Earnings Call Highlights: Strong Revenue Growth and ...

Smith & Nephew PLC (SNN) reports robust financial performance with significant revenue growth, margin expansion, and strategic advancements despite facing global headwinds.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MarketBeat
Mar 2, 2026

Smith & Nephew SNATS Q4 Earnings Call Highlights

Smith & Nephew SNATS (NYSE:SNN) executives struck an optimistic tone in the company’s fourth-quarter and full-year 2025 results presentation, pointing to a “strong finish” that landed at the high end of management’s guidance for revenue growth, margin expansion, and free cash flow. Chief Executi

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.